Monday, January 06, 2014 12:53:05 PM
China reports new bird flu virus case
Last Updated: Monday, January 06, 2014, 04:24
Beijing: A human case of H7N9 was reported in east China's Zhejiang province Sunday, authorities said in a statement.
The patient is a 34-year-old woman surnamed Cai, who is from the city of Zhuji. She was confirmed to be infected with the bird flu virus Saturday, Xinhua quoted the provincial health and family planning commission as saying.
By 1 pm on Sunday, she was still in critical condition at a local hospital, the statement said.
This is the first case to be reported in Zhejiang this year. In November, two cases were reported in the province.
It is the second case to be reported in China this year.
IANS
First Published: Monday, January 06, 2014, 04:24
http://zeenews.india.com/news/world/china-reports-new-bird-flu-virus-case_901733.html
Influenza A virus subtype H7N9
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Influenza A virus subtype H7N9 Electron micrograph of Influenza A H7N9.png
Electron micrograph of Influenza A (H7N9).
Date March 31, 2013–present
Location China: Anhui, Jiangsu, Zhejiang, Hangzhou, Hunan, Jiangxi, Fujian, Beijing, Guangdong
Hong Kong
Taiwan
Casualties
48 deaths (as of 26, December, 2013)[1]
147 cases (China)[1]
2 cases (Hong Kong)[2][3]
2 cases (Taiwan)[4]
H7N9 is a bird flu strain of the species Influenza virus A (avian influenza virus or bird flu virus). Avian influenza A H7 viruses normally circulate amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have infected humans in 2013 in China.[5] Most of the reported cases of human infection have resulted in severe respiratory illness.[6] In the month following the report of the first case, more than 100 people had been infected, an unusually high rate for a new infection; a fifth of those patients had died, a fifth had recovered, and the rest remained critically ill.[7] The World Health Organization (WHO) has identified H7N9 as "...an unusually dangerous virus for humans."[8] As of 6 November 2013, 139 confirmed cases have been reported, resulting in 45 deaths.[9] As of 7 December 2013, 2 additional confirmed cases, and 4 potential cases, have been reported in Hong Kong.
http://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H7N9
Last Updated: Monday, January 06, 2014, 04:24
Beijing: A human case of H7N9 was reported in east China's Zhejiang province Sunday, authorities said in a statement.
The patient is a 34-year-old woman surnamed Cai, who is from the city of Zhuji. She was confirmed to be infected with the bird flu virus Saturday, Xinhua quoted the provincial health and family planning commission as saying.
By 1 pm on Sunday, she was still in critical condition at a local hospital, the statement said.
This is the first case to be reported in Zhejiang this year. In November, two cases were reported in the province.
It is the second case to be reported in China this year.
IANS
First Published: Monday, January 06, 2014, 04:24
http://zeenews.india.com/news/world/china-reports-new-bird-flu-virus-case_901733.html
Influenza A virus subtype H7N9
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Influenza A virus subtype H7N9 Electron micrograph of Influenza A H7N9.png
Electron micrograph of Influenza A (H7N9).
Date March 31, 2013–present
Location China: Anhui, Jiangsu, Zhejiang, Hangzhou, Hunan, Jiangxi, Fujian, Beijing, Guangdong
Hong Kong
Taiwan
Casualties
48 deaths (as of 26, December, 2013)[1]
147 cases (China)[1]
2 cases (Hong Kong)[2][3]
2 cases (Taiwan)[4]
H7N9 is a bird flu strain of the species Influenza virus A (avian influenza virus or bird flu virus). Avian influenza A H7 viruses normally circulate amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have infected humans in 2013 in China.[5] Most of the reported cases of human infection have resulted in severe respiratory illness.[6] In the month following the report of the first case, more than 100 people had been infected, an unusually high rate for a new infection; a fifth of those patients had died, a fifth had recovered, and the rest remained critically ill.[7] The World Health Organization (WHO) has identified H7N9 as "...an unusually dangerous virus for humans."[8] As of 6 November 2013, 139 confirmed cases have been reported, resulting in 45 deaths.[9] As of 7 December 2013, 2 additional confirmed cases, and 4 potential cases, have been reported in Hong Kong.
http://en.wikipedia.org/wiki/Influenza_A_virus_subtype_H7N9
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM

